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PURPOSE. The mechanisms involved in reactivations of latent
ocular Toxoplasma gondii (Tg) infections in immunocompe-
tent patients are poorly understood. In view of the possible
role of T cells in the immunopathogenesis of the disease,
ocular infiltrating T cells obtained from patients with recurrent
ocular toxoplasmosis were characterized phenotypically and
functionally.
METHODS. Ocular infiltrating T cells were recovered from vit-
reous fluid (VF) samples of 10 patients with active recurrent
ocular toxoplasmosis. Two patients with uveitis of other ori-
gins were included as control subjects. T-cell lines (TCLs) were
generated by mitogenic stimulation and tested for reactivity to
Tg and human retinal protein extracts. The TCLs of three
patients were cloned by limiting dilution. Tg-reactive T-cell
clones (TCCs) were characterized with respect to their pheno-
type, T-cell receptor variable (TCR V)-b gene usage, HLA re-
striction, and cytokine secretion profile.
RESULTS. Reactivity to Tg could be detected only in the TCLs of
patients with ocular toxoplasmosis. None of the TCLs showed
reactivity to human retinal antigens. All tested intraocular Tg-
specific TCCs (n 5 23) were CD31CD41 and displayed differ-
ential TCR Vb usage. Twenty-one TCCs were HLA-DR re-
stricted and two TCCs were restricted by HLA-DP. The majority
of the intraocular Tg-specific TCCs showed a bias toward a
T-helper (Th)0-Th2 cytokine profile.
CONCLUSIONS. The data indicate that T cells specific for the
triggering microorganism infiltrate the eye of patients with
recurrent ocular toxoplasmosis. The functional characteristics
of the VF-derived Tg-specific T cells and their presence at the
site of inflammation suggest their involvement in the local
inflammatory response of ocular toxoplasmosis. (Invest Oph-
thalmol Vis Sci. 2001;42:3228–3232)
Toxoplasmosis is caused by the obligate intracellular proto-zoan Toxoplasma gondii (Tg). It is estimated that at least
500 million people worldwide are infected with Tg.1 Human
infection may occur either by the congenital or acquired route.
Congenital toxoplasmosis is caused by transplacental transmis-
sion of Tg tachyzoites, whereas acquired infection results from
ingestion of food, soil, or water contaminated with Tg cysts or
oocysts.2 Infection of an immunocompetent host normally
induces a strong type 1 T-cell (Th1)–mediated immune re-
sponse. This response is characterized by high levels of inter-
feron (IFN)-g, involved in killing of intracellular residing para-
sites. This rapidly controls the dividing tachyzoite stage of the
parasite.3 The parasite may persist for life in the host by
sequestration within tissue cysts containing the quiescent bra-
dyzoite stage. The high frequency of Tg cysts in the eye and the
brain compared with extraneural tissues may be related to the
immune privileged state of these tissues in which inflammatory
responses are actively suppressed.4
Ocular infection with Tg is a major cause of visual impair-
ment throughout the world.5 Most cases of ocular toxoplasmo-
sis are believed to result from reactivation of latent congenital
or acquired infections.6 T cells have been suggested to play a
pivotal role in these recurrences.3,7 Flow cytometric analyses
have shown the predominance of T cells among the inflamma-
tory cells located in the aqueous humor in patients with active
disease,8 and the percentages of activated T cells in the eye are
higher than in the peripheral blood.9,10 Thus far, the antigen
specificity and functional properties of these ocular infiltrating
T cells have not been analyzed.
To determine the role of T cells in the immunopathology of
recurrent ocular toxoplasmosis, a study was designed to isolate
and characterize the ocular infiltrating T cells recovered from
the vitreous fluid (VF) of 10 patients with active disease. As a
control, two patients with different origins of uveitis were
included. We have tested whether the VF-derived T-cell lines
(TCLs) and resultant T-cell clones (TCCs) were specific for Tg
antigens or human retinal antigens. The TCC were character-
ized with respect to their phenotype, T-cell receptor variable
(TCR V)-b gene usage, HLA-restriction of antigen recognition,
and cytokine secretion profile.
MATERIALS AND METHODS
Patients
Ten immunocompetent patients included in this study had unilateral
presumed ocular toxoplasmosis and underwent a surgical pars plana
vitrectomy for therapeutic or diagnostic reasons during an episode of
active retinitis lasting for a minimum of 1 week at the time of vitrec-
tomy. The characteristics, diagnosis, reasons for surgical intervention,
and preoperative treatment of the patients studied are listed in Table 1.
The diagnosis of ocular toxoplasmosis was based on the typical aspect
of the retinal lesions: full-thickness necrotizing retinitis, adjacent to a
chorioretinal scar, with overlying vitreous cellular reaction. In some
cases, a diagnostic vitrectomy was performed by the surgeon to ex-
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clude other causes of necrotizing retinitis (patients 2, 3, and 5) or
because the density of the vitreous haze precluded visibility of the
fundus (patients 4, 6, and 9). In all patients, the clinical diagnosis was
confirmed by paired serologic examination of VF and serum samples,11
which showed evidence of intraocular synthesis of antibodies against
Tg (Goldmann-Witmer coefficient 5 antibody titer VF/serum 3 total
IgG serum/VF $ 3; Table 1). The presence of Tg DNA in the VF
samples was determined by PCR, as described previously (Table 1).11
The present study was performed according the Declaration of Hel-
sinki, and informed consent was obtained from all patients. Two
patients with uveitis of different origins (i.e., panuveitis and pars
planitis), who were undergoing a vitrectomy, were included in the
study as negative control subjects for proliferation of intraocular T cells
in response to Tg antigen (Table 1; patients 11 and 12).
Collection of VF and Peripheral Blood
Undiluted VF was washed twice with RPMI-1640 (Gibco, Grand Island,
NY) supplemented with 10% pooled heat-inactivated normal human
serum (NHS; Central Laboratory Blood Transfusion Service, Amster-
dam, The Netherlands) and antibiotics. This medium is further referred
to as culture medium. Peripheral blood was collected into heparinized
tubes, and peripheral blood mononuclear cells (PBMCs) were obtained
by density centrifugation over a single-density gradient (Ficoll-Hypaque
(Pharmacia, Uppsala, Sweden) and stored in liquid nitrogen for further
use.
Generation of TCLs and TCCs
The TCLs were obtained by nonspecific stimulation of VF-derived cells
with 10 mg/ml phytohemagglutinin (PHA; Gibco), in the presence of a
feeder mixture of g-irradiated allogeneic PBMCs (3000 rad; 105/well),
in culture medium supplemented with 20 U/ml recombinant interleu-
kin (rIL)-2 (Gibco). The T-cell cultures were incubated in 96-well,
round-bottomed tissue culture plates (Costar, Cambridge, MA) for 2
weeks at 37°C in a humidified atmosphere containing 5% CO2.
The TCCs were generated from the VF-derived TCLs by limiting
dilution in microwell plates (Terasaki-Microwell; Nunc, Roskilde, Den-
mark) in the presence of irradiated allogeneic PBMCs, PHA, and rIL-2 as
described by Hermann et al.12 After 14 days, expanding clones were
transferred to 96-well plates in culture medium supplemented with 20
U/ml rIL-2. The TCCs were restimulated every 10 to 14 days with 1
mg/ml PHA in the presence of a feeder mixture of irradiated allogeneic
PBMCs, as described by Verjans et al.13 Only in patients 1, 4, and 8
were TCCs generated in sufficient numbers to make subsequent testing
possible.
Tg and Human Retinal Antigen Extracts
A crude Tg antigen preparation was a gift of Frans van Knapen (De-
partment of Parasitology, National Institute of Public Health, Bilthoven,
The Netherlands) and was obtained as previously described by Hughes
et al.14 Briefly, tachyzoites of the RH strain of Tg were harvested from
the peritoneal exudates of Tg-infected mice, washed with saline, and
disrupted by repeated cycles of freeze thawing. Human retinal extract
was obtained from surplus material of donor eyes, as described previ-
ously.15
T-Cell Proliferation Assay
Ten to 14 days after the last stimulation, T cells were washed three
times in RPMI-1640 plus 5% heat-inactivated fetal calf serum (FCS;
Gibco) to remove all rIL-2. The antigen specificity of the TCLs and
TCCs was assayed in triplicate by culturing the T cells (2 3 104/well)
in culture medium in 96-well, round-bottomed culture plates in the
presence of specific antigens and g-irradiated autologous PBMCs (3000
rad; 105/well) as a source of antigen-presenting cells. The cells were
cultured for 3 days at 37°C in a CO2-incubator and labeled with
[3H]-thymidine (1 mCi/well; Amersham International, Amersham, UK)
during the last 18 hours of incubation. The Tg antigen and human
retinal protein extracts were used at final concentrations of 10 and 100
mg/ml respectively, which had been shown to yield maximal T-cell
proliferation in preliminary experiments (data not shown). Subclasses
of HLA class II restriction determinants were characterized by blocking
the Tg-specific T-cell proliferation with appropriate dilutions of the
following monoclonal antibodies (mAbs): anti-HLA DR (B.8.11.2; a gift
of Frits Koning, Department of Immunohematology, University of
Leiden, The Netherlands), anti-HLA-DQ (SPV L3-8; a gift of Hergen
Spits, The Netherlands Cancer Institute, Amsterdam, The Netherlands)
and anti-HLA-DP (B21/7; Becton Dickinson, Mountain View, CA) in a
standard proliferation assay. The stimulation index (SI) was calculated
as the ratio of antigen-stimulated proliferation to the background pro-
TABLE 1. Characteristics of Patients with Ocular Toxoplasmosis and Control Subjects Included in the Present Study
Patient Sex Age (y)
Disease
Activity*
Reason for
Vitrectomy Preoperative Treatment G-WC† PCR Tg‡
Clinical
Diagnosis
1 M 32 1 Macular pucker None 39 2 Toxoplasmosis
2 F 62 2 Diagnostic Subconjunctival betamethasone,
topical prednisolone
6 1 Toxoplasmosis
3 F 75 2 Diagnostic Topical prednisolone 11 1 Toxoplasmosis
4 F 29 4 Diagnostic Topical prednisolone 15 ND Toxoplasmosis
5 M 26 2 Diagnostic Systemic prednisone, pyrimethamine,
sulphadiazine, topical prednisolone
40 2 Toxoplasmosis
6 F 66 3 Diagnostic Subconjunctival betamethasone,
topical dexamethasone
22 1 Toxoplasmosis
7 M 22 2 Retinal
detachment
Topical dexamethasone 12 2 Toxoplasmosis
8 F 29 2 Retinal
detachment
Topical prednisolone 7 2 Toxoplasmosis
9 F 37 3 Diagnostic Topical prednisolone 111 2 Toxoplasmosis
10 M 20 2 Retinal
detachment
Systemic prednisone, pyrimethamine,
sulphadiazine, topical prednisolone
27 ND Toxoplasmosis
11 F 59 3 Diagnostic Topical dexamethasone ,1 2 Panuveitis
12 F 52 3 Diagnostic Systemic prednisone ,1 ND Pars planitis
* Disease activity was assessed by grading the severity of vitreous activity, as measured by the amount of vitreous cells and haze, using the
criteria of Nussenblatt et al.33
† Goldmann-Witmer coefficient to T. gondii.
‡ 1 or 2, positive or negative T. gondii–specific PCR product detected. ND, not done.
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liferation—T cells incubated with PBMCs without antigen. An SI of
more than three was considered positive. The SD in all assays was less
than 15% of the mean value.
T-Cell Phenotype and TCR Vb Gene Usage
T cells were labeled with fluorescein-conjugated mAb against CD4 and
CD8 or phycoerythrin-conjugated mAb directed toward CD3 (Dako,
Glostrup, Denmark). The labeled cells were analyzed by flow cytom-
etry (FACScan; Becton Dickinson).
The TCR Vb gene usage of the TCCs was determined by RT-PCR as
described previously.16 Briefly, total RNA was isolated from 105 to 106
T cells by use of extraction agent (RNAzol; Campro Scientific, Elst, The
Netherlands) and cDNA generated by using reverse transcriptase and
oligo-dT (Gibco). For the PCR amplification on cDNA, 23 TCR Vb-
specific 59 sense primers in combination with a 39 antisense Cb primer
were used.16 PCR products were fractionated according to size by
electrophoresis on a 1.5% agarose gel and the amplicons visualized
after staining with ethidium bromide.
Induction and Measurement of Cytokine Release
by TCCs
For analysis of cytokine production, quiescent T cells were washed
three times in RPMI-1640 plus 5% FCS and restimulated with a mito-
genic pair of mAbs directed against CD2 (clone CLB-11.1/1 and CLB-
T11.2/1; CLB, Amsterdam, The Netherlands) in combination with an
mAb directed against CD28 (clone CLB-28/1; CLB) in culture medium
in 96-well tissue culture plates at 2 3 105 cells per well. This method
has been shown to yield high cytokine production.17 The amounts of
IL-4 and IFN-g secreted in the supernatants, collected after 24 hours,
were determined by solid-phase sandwich ELISA, as described previ-
ously.17 If the production of IL-4 was less than 10% of the production
of IFN-g, the cytokine pattern was arbitrarily classified as Th type 1.
Similarly, if the production of IFN-g was less than 10% of the produc-
tion of IL-4, the cytokine pattern was classified as Th type 2. The
cytokine pattern was classified as Th type 0 in case of intermediate
mixtures of IFN-g and IL-4 secretion levels.
RESULTS
Generation of TCLs from VF Samples of Patients
with Recurrent Ocular Toxoplasmosis
Diagnostic analyses were performed on VF samples, obtained
for therapeutic or diagnostic purposes, from 10 patients clini-
cally suspected as having recurrent ocular toxoplasmosis. Pro-
duction of intraocular antibody to Tg was demonstrated in all
patients. PCR analyses revealed the presence of Tg DNA in the
VF samples of patients 2, 3, and 6 (Table 1). In the VF samples
of patients 11 and 12, who had panuveitis and pars planitis, no
evidence for local Tg-specific antibodies or Tg DNA could be
detected (Table 1). On the basis of clinical and laboratory data,
the ocular lesions of patients 1 to 10 were defined as recurrent
ocular toxoplasmosis.
The VF-derived inflammatory cells were expanded by one
round of nonspecific stimulation with PHA in the presence of
IL-2 and g-irradiated allogeneic feeder cells. The VF-derived
TCLs were screened for reactivity to crude protein lysates of Tg
and human retinas. Significant Tg-specific proliferative re-
sponses were detected only in the TCLs of the patients with
recurrent ocular toxoplasmosis (Table 2; patients 1–10). The SI
of the TCLs varied from 3.1, which is just above threshold, to
243.5 but did not correlate with disease activity, Goldmann-
Witmer coefficient, or Tg DNA PCR results (Table 1). None of
the TCLs tested showed reactivity to the human retinal extract
(Table 2).
Characterization of VF-Derived Tg-Specific TCCs
To analyze the intraocular Tg-specific T-cell response at the
clonal level, the T cells of the VF-derived TCLs of patients 1, 4,
and 8 were cloned representatively by limiting dilution. A
substantial number of TCCs were Tg specific. Of the TCCs
obtained from patients 1, 4, and 8, 65 (31%) of 208, 17 (74%)
of 23, and 6 (14%) of 44 were Tg specific, respectively. In all
three patients, none of the TCCs was reactive to human retinal
extract (data not shown). The Tg-specific TCCs, which after
four rounds of restimulation had produced sufficient numbers
of cells, were subjected to further testing. They were charac-
terized with respect to their phenotype, HLA-restriction of
antigen recognition, and TCR Vb usage (Table 3). All 23 Tg-
specific TCCs were CD31CD41. Nineteen of 21 Tg-specific
TCCs tested were restricted by HLA-DR, whereas two TCCs
(one of patient 1 and one of patient 8) showed HLA-DP restric-
tion. The TCR Vb gene usage of the Tg-specific TCCs of
patients 4 and 8 was diverse (not tested for patient 1).
The production of the cytokines IFN-g and IL-4 by the
Tg-specific TCCs was determined (Table 3). In patient 4, who
underwent a diagnostic vitrectomy at the time of active inflam-
mation, 4 of 10 intraocular TCCs had a Th2-like phenotype. In
contrast, almost all intraocular TCCs from patient 8 (disease
activity grade 2) and patient 1 (disease activity grade 1) were
Th0-like cells. Both patients underwent a vitrectomy at a stage
when ocular inflammation had almost resolved.
DISCUSSION
In the present study, we show that a reactivation of latent
ocular toxoplasmosis is associated with an ocular infiltration of
a polyclonal Tg-specific T-cell population. In contrast, retinal
autoantigen-specific T cells could not be detected in the VF-
derived TCLs. This does not exclude the possibility that they
may be present in the eye, either at a very low frequency or at
the earliest stages of the inflammation. However, the signifi-
cant SI in response to Tg antigens of the VF-derived TCLs from
all patients with recurrent ocular toxoplasmosis compared
with two control patients, and the high frequency of VF-
derived Tg-specific TCCs generated from three patients, sug-
gest a predominant intraocular Tg-specific T-cell response in
the patients analyzed. Different therapies, including systemic,
periocular, and topical corticosteroids were administered to
the patients at the time of vitreous sampling (Table 1). Al-
TABLE 2. Antigen-Specific Proliferative Responses of VF-Derived TCLs
Patient
[3H]-Thymidine Incorporation
Medium Tg Retina
1 977 6 198 5,697 6 1,615 832 6 79
2 76 6 12 12,895 6 492 140 6 10
3 603 6 452 10,160 6 2,152 268 6 274
4 168 6 115 5,946 6 278 34 6 21
5 108 6 23 26,302 6 4,121 56 6 12
6 64 6 17 4,439 6 456 61 6 44
7 91 6 15 7,995 6 1,100 38 6 19
8 311 6 77 10,630 6 1,891 202 6 45
9 246 6 54 11,574 6 3,180 208 6 32
10 260 6 128 803 6 122 ND
11 154 6 8 122 6 19 ND
12 79 6 14 107 6 12 72 6 14
T cells were incubated with autologous PBMCs in the presence of
medium, T. gondii (Tg), or human retina protein extract (Retina). Data
are expressed as the mean counts per minute 6 SD of triplicate
cultures. ND, not done.
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though these immunosuppressive treatments may have influ-
enced the total number of T cells in the vitreous samples, they
did not seem to affect the ability of the TCLs and TCCs,
generated from the VF, to respond to Tg antigens (Tables 2, 3).
In mice, both CD41 and CD81 T cells have been described
to play a protective role in acute and chronic Tg infection.3
Although the VF-derived TCLs contained CD81 T cells (data
not shown), none of the Tg-specific TCCs obtained from these
lines had this phenotype. It is possible that the type of assay or
nature of the Tg antigen used—that is, proliferation assays
using exogenous antigen preparations, account for the recov-
ery of CD41 and not CD81 Tg-specific TCCs in the present
study. Nevertheless, a similar CD41 predominance has been
reported for Tg-specific human TCCs generated from periph-
eral blood,18–20 even when autologous PBMCs infected with
live Tg tachyzoites were used to stimulate the TCCs.21 It has
been suggested that in chronic infections, as in our patient
group, CD41 T cells predominate, whereas in recently infected
patients the majority of Tg-specific T cells are CD81 T cells.22
T-cell derived cytokines have been demonstrated to be
critical in determining the outcome of Tg infections.3,23 The
Th1 cytokines IFN-g24 and IL-225 are considered to mediate
protective effects. Th2 cytokines, such as IL-426,27 and IL-
10,28,29 have been shown to be associated with progression of
disease. Increased intraocular levels of both IFN-g and IL-10
have previously been reported in patients with ocular toxo-
plasmosis.30 As in leishmaniasis,31 the balance between these
Th-cell subsets may determine the outcome of Tg infections.32
By analyzing the cytokine secretion profile of the Tg-specific
VF-derived TCCs obtained from three patients, two observa-
tions can be made. First, it was observed that most clones
displayed a Th0-Th2 phenotype. This deviates from the ex-
pected Th1-like response associated with peripheral infec-
tion.3 It is conceivable that the microenvironment of the eye
induces T cells to shift from the detrimental Th1 phenotype
toward a less harmful Th0-Th2 phenotype. Second, the clones
from patient 4 with active disease were mostly Th2 compared
with the Th0 clones from the eyes of patients 1 and 8 who
were in the recovery phase of the disease.
In conclusion, this study is the first to demonstrate the
presence of a T-cell response specific for the inciting micro-
organism in VF samples of patients with active recurrent ocular
toxoplasmosis. The functional characteristics of the Tg-specific
T cells and their presence at the site of inflammation suggest
their involvement in the local inflammatory response of ocular
toxoplasmosis. An important question is whether Tg-specific
T-cell responses have a beneficial or a deleterious effect. The
immune-mediated damage to the retina may in fact have a more
detrimental impact than the cytopathic effect of the parasite
itself. Further characterization of their antigenic specificity and
functional properties may have implications for future vaccine
development against this blinding disease.
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